Insider Transactions in Q3 2025 at Theravance Biopharma, Inc. (TBPH)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 20
2025
|
Aine Miller SVP, DEV & HEAD OF IRE OFFICE |
SELL
Payment of exercise price or tax liability
|
Direct |
6,989
-3.25%
|
$90,857
$13.39 P/Share
|
|
Aug 20
2025
|
Aziz Sawaf SVP & CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
9,368
-2.57%
|
$121,784
$13.39 P/Share
|
|
Aug 20
2025
|
Rick E Winningham CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
15,394
-0.89%
|
$200,122
$13.39 P/Share
|
|
Aug 20
2025
|
Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS |
SELL
Payment of exercise price or tax liability
|
Direct |
9,096
-2.78%
|
$118,248
$13.39 P/Share
|
|
Aug 20
2025
|
Brett A. Grimaud SVP, GEN COUNSEL AND SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
9,762
-2.54%
|
$126,906
$13.39 P/Share
|
|
Jul 14
2025
|
Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS |
SELL
Open market or private sale
|
Direct |
10,000
-1.0%
|
$110,000
$11.39 P/Share
|